NCT01953458View on ClinicalTrials.gov

Therapeutic Option for Hepatitis B and C: a French Cohort

UnknownOBSERVATIONAL
Enrollment

20,902

Participants

Timeline

Start Date

August 6, 2012

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Viral Hepatitis BViral Hepatitis C
Trial Locations (1)

Unknown

Multiple Locations

Sponsors
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Gilead Sciences

INDUSTRY

collaborator

Janssen-Cilag Ltd.

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Roche Pharma AG

INDUSTRY

lead

ANRS, Emerging Infectious Diseases

OTHER_GOV